rs115475262

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_018100.4(EFHC1):​c.1820A>G​(p.Asn607Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000258 in 1,614,166 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. N607N) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00014 ( 1 hom. )

Consequence

EFHC1
NM_018100.4 missense

Scores

2
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 0.768

Publications

1 publications found
Variant links:
Genes affected
EFHC1 (HGNC:16406): (EF-hand domain containing 1) This gene encodes an EF-hand-containing calcium binding protein. The encoded protein likely plays a role in calcium homeostasis. Mutations in this gene have been associated with susceptibility to juvenile myoclonic epilepsy and juvenile absence epilepsy. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2010]
EFHC1 Gene-Disease associations (from GenCC):
  • juvenile myoclonic epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0037873387).
BP6
Variant 6-52490319-A-G is Benign according to our data. Variant chr6-52490319-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 287376.
BS2
High AC in GnomAd4 at 206 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EFHC1NM_018100.4 linkc.1820A>G p.Asn607Ser missense_variant Exon 10 of 11 ENST00000371068.11 NP_060570.2
EFHC1NM_001172420.2 linkc.1763A>G p.Asn588Ser missense_variant Exon 11 of 12 NP_001165891.1
EFHC1NR_033327.2 linkn.3146A>G non_coding_transcript_exon_variant Exon 9 of 10

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EFHC1ENST00000371068.11 linkc.1820A>G p.Asn607Ser missense_variant Exon 10 of 11 1 NM_018100.4 ENSP00000360107.4

Frequencies

GnomAD3 genomes
AF:
0.00135
AC:
206
AN:
152232
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000350
AC:
88
AN:
251136
AF XY:
0.000243
show subpopulations
Gnomad AFR exome
AF:
0.00505
Gnomad AMR exome
AF:
0.000174
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000144
AC:
210
AN:
1461816
Hom.:
1
Cov.:
32
AF XY:
0.000118
AC XY:
86
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.00535
AC:
179
AN:
33472
American (AMR)
AF:
0.000268
AC:
12
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
8.99e-7
AC:
1
AN:
1111962
Other (OTH)
AF:
0.000265
AC:
16
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
12
24
36
48
60
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00135
AC:
206
AN:
152350
Hom.:
0
Cov.:
32
AF XY:
0.00132
AC XY:
98
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.00481
AC:
200
AN:
41584
American (AMR)
AF:
0.000327
AC:
5
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68030
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000490
Hom.:
1
Bravo
AF:
0.00129
ESP6500AA
AF:
0.00499
AC:
22
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000478
AC:
58

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:2
Dec 14, 2015
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 18, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 21, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1820A>G (p.N607S) alteration is located in exon 10 (coding exon 10) of the EFHC1 gene. This alteration results from a A to G substitution at nucleotide position 1820, causing the asparagine (N) at amino acid position 607 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

Absence seizure;C1850778:Myoclonic epilepsy, juvenile, susceptibility to, 1 Benign:1
Oct 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

EFHC1-related disorder Benign:1
Jan 06, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
6.4
DANN
Benign
0.85
DEOGEN2
Benign
0.0
.;.;T;T;T;T;.;T;.;.
Eigen
Benign
-0.84
Eigen_PC
Benign
-0.86
FATHMM_MKL
Benign
0.041
N
LIST_S2
Benign
0.77
T;.;T;T;T;T;T;T;.;T
MetaRNN
Benign
0.0038
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.0
.;.;L;.;.;.;.;.;.;.
PhyloP100
0.77
PrimateAI
Benign
0.34
T
PROVEAN
Benign
0.0
.;.;N;.;.;.;.;.;.;N
REVEL
Benign
0.0
Sift
Pathogenic
0.0
.;.;D;.;.;.;.;.;.;T
Sift4G
Pathogenic
0.0
.;.;T;.;.;.;.;.;.;T
Vest4
0.0
ClinPred
0.011
T
GERP RS
1.7
Varity_R
0.033
gMVP
0.024
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115475262; hg19: chr6-52355117; API